NRLU 13
Latest Information Update: 20 Jun 2006
At a glance
- Originator Poniard Pharmaceuticals
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer